Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case

Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in ophthalmology 2017-07, Vol.8 (2), p.370-374
Main Authors: Kapoor, Kapil G., Sim, Jennifer
Format: Article
Language:English
Subjects:
Activities of daily living
Case Report
Case reports
Central serous chorioretinopathy
Corticosteroids
Pathogenesis
Patients
Photoreceptors
Spironolactone
Steroids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy of spironolactone as an effective agent in countering CSCR secondary to steroid use. This challenge-rechallenge case may be helpful to clinicians in delineating a treatment paradigm for these patients.
ISSN:1663-2699
1663-2699
DOI:10.1159/000477757